Guardian Pharmacy Services, Inc.
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | 314.39M | 287.72M | 287.72M | 262.74M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 314.39M | 287.72M | 287.72M | 262.74M | |
| Cost of Revenue | 253.52M | 229.53M | 229.53M | 210.55M | |
| Gross Profit | 60.88M | 58.19M | 58.19M | 52.19M | |
| SG&A Expenses | 165.49M | 45.73M | 45.73M | 58.52M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 419.01M | 275.25M | 275.25M | 269.07M | |
| Operating Income | -104.61M | 12.47M | 12.47M | -6.33M | |
| Income Before Tax | -105.64M | 11.47M | 11.47M | -7.00M | |
| Income Tax Expenses | 176.00K | 0.00 | -- | -- | |
| Earnings from Continuing Operations | -105.82M | 11.47M | 11.47M | -7.00M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -6.82M | -4.77M | -4.77M | -4.30M | |
| Net Income | -112.64M | 6.71M | 6.71M | -11.29M | |
| EBIT | -104.61M | 12.47M | 12.47M | -6.33M | |
| EBITDA | -99.62M | 17.28M | 17.28M | -1.69M | |
| EPS Basic | -2.00 | -0.11 | -- | -- | |
| Normalized Basic EPS | -1.19 | 0.04 | -- | -- | |
| EPS Diluted | -2.00 | -0.11 | -- | -- | |
| Normalized Diluted EPS | -1.19 | 0.04 | -- | -- | |
| Average Basic Shares Outstanding | 61.14M | 61.14M | -- | -- | |
| Average Diluted Shares Outstanding | 61.14M | 61.14M | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -10.93% | 177.05% | 177.05% | -57.86% | |
